The Iranian Journal of Obstetrics, Gynecology and Infertility

The Iranian Journal of Obstetrics, Gynecology and Infertility

The Frequency of Pro12Ala Genotypes of the PPARγ Gene in Diabetic and Non-Diabetic Patients with Polycystic Ovary Syndrome Referred to Imam Reza and Ghaem Hospitals, Mashhad, 2021

Document Type : Original Article

Authors
Nafiseh Saghafi 1
Mahsa Khajoee 2
Tayebeh Hamzehloei 3
1 Professor, Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
2 Obstetrician and Gynecologist, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
3 Associate Professor, Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
10.22038/ijogi.2026.93283.6625
Abstract
Introduction: The Pro12Ala polymorphism of the PPARγ gene affects insulin sensitivity, but its distribution in Iranian patients with polycystic ovary syndrome (PCOS) based on diabetic status has been less investigated. This study was conducted with aim to determine the frequency of Pro12Ala genotypes in diabetic and non-diabetic PCOS patients in Mashhad.
Methods: This cross-sectional study was conducted in 2020 on 200 women with PCOS based on Rotterdam criteria, including 100 diabetic and 100 non-diabetic patients. Demographic information including age and body mass index (BMI) was recorded for all participants. Genotyping was performed using PCR-RFLP method, and fasting blood glucose (FBG), glycated hemoglobin (HbA1c), and homeostatic model assessment for insulin resistance (HOMA-IR) were evaluated. Data analysis was performed using SPSS software (version 26) with Chi-square, Fisher's exact, independent t-test, and analysis of covariance (ANCOVA). P<0.05 was considered significant.
Results: The mean age and BMI were significantly higher in the diabetic group compared to the non-diabetic group (p<0.05). The frequency of the Ala allele was significantly lower in the diabetic group (4.5%) than in the non-diabetic group (11%) (p<0.05). The odds ratio for the presence of the Ala allele in the non-diabetic group compared to the diabetic group was 2.62 (95% CI: 1.15-5.98). After adjusting for age and BMI using ANCOVA, the difference in HOMA-IR between the two groups remained significant (p=0.012). Also, carriers of the Ala allele showed lower HOMA-IR values compared to individuals with the Pro/Pro genotype, although this difference was not statistically significant (p>0.05).
Conclusion: The Pro12Ala polymorphism has a lower prevalence in PCOS patients with diabetes. The findings of this study suggest that the Ala allele may be associated with a reduced risk of developing type 2 diabetes in women with PCOS (OR=2.62; 95% CI: 1.15-5.98).
Keywords
Polycystic Ovary Syndrome
Polymorphism
PPAR Gamma
Pro12Ala
Type 2 Diabetes
Subjects
1.     ESHRE TR, ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and sterility 2004; 81(1):19-25.
2.     Hara M, Alcoser SY, Qaadir A, Beiswenger KK, Cox NJ, Ehrmann DA. Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro12Ala polymorphism in the PPARγ gene. The Journal of Clinical Endocrinology & Metabolism 2002; 87(2):772-5.
3.     Gouda HN, Sagoo GS, Harding AH, Yates J, Sandhu MS, Higgins JP. The association between the peroxisome proliferator-activated receptor-γ2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. American journal of epidemiology 2010; 171(6):645-55.
4.     Rooki H, Haerian MS, Azimzadeh P, Ebrahimi M, Mirhafez R, Ferns G, et al. Distribution and genotype frequency of the C1431T and pro12ala polymorphisms of the peroxisome proliferator activator receptor gamma gene in an Iranian population. Indian Journal of Human Genetics 2013; 19(4):423.
5.     Motavallian A, Andalib S, Vaseghi G, Mirmohammad-Sadeghi H, Amini M. Association between PRO12ALA polymorphism of the PPAR-γ2 gene and type 2 diabetes mellitus in Iranian patients. Indian journal of human genetics 2013; 19(2):239.
6.     Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature genetics 2000; 26(1):76-80.
7.     Hahn S, Fingerhut A, Khomtsiv U, Khomtsiv L, Tan S, Quadbeck B, et al. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome. Clinical Endocrinology 2005; 62(5):573-9.
8.     Meshkani R, Taghikhani M, Larijani B, Bahrami Y, Khatami S, Khoshbin E, et al. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPARγ-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population. Clinical Chemistry & Laboratory Medicine 2007; 45(4).
9.     Yilmaz M, Ali Ergün M, Karakoç A, Yurtçu E, Çakir N, Arslan M. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ gene in women with polycystic ovary syndrome. Gynecological Endocrinology 2006; 22(6):336-42.
10.  He J, Wang L, Liu J, Liu F, Li X. A meta-analysis on the association between PPAR-γ Pro12Ala polymorphism and polycystic ovary syndrome. Journal of assisted reproduction and genetics 2012; 29(7):669-77.
11.  Orio Jr F, Palomba S, Cascella T, Di Biase S, Labella D, Russo T, et al. Lack of an association between peroxisome proliferator-activated receptor-γ gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism 2004; 89(10):5110-5.
12.  Christopoulos P, Mastorakos G, Gazouli M, Deligeoroglou E, Katsikis I, Diamanti‐Kandarakis E, et al. Peroxisome proliferator‐activated receptor‐γ and‐δ polymorphisms in women with polycystic ovary syndrome. Annals of the New York Academy of Sciences 2010; 1205(1):185-91.
13.  Gu BH, Baek KH. Pro12Ala and His447His polymorphisms of PPAR-γ are associated with polycystic ovary syndrome. Reproductive biomedicine online 2009; 18(5):644-50.
14.  Dragojevič J, Marc J, Mlinar B. Association between Pro12Ala and His477His polymorphisms in PPARG gene and insulin resistance in patients with polycystic ovary syndrome. Biochemia Medica 2008; 18(3):342-50.
The Iranian Journal of Obstetrics, Gynecology and Infertility
Volume 29, Issue 1
March 2026
Pages 1-8